Targeting breast cancer stem cells directly to treat refractory breast cancer

For patients with refractory breast cancer (BC), integrative immunotherapies are emerging as a critical component of treatment. However, many patients remain unresponsive to treatment or relapse after a period. Different cells and mediators in the tumor microenvironment (TME) play important roles in...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Liping, Han, Juan, Lin, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213424/
https://www.ncbi.nlm.nih.gov/pubmed/37251931
http://dx.doi.org/10.3389/fonc.2023.981247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213424/
https://www.ncbi.nlm.nih.gov/pubmed/37251931
http://dx.doi.org/10.3389/fonc.2023.981247

Ejemplares similares